Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids
Biomolecules · 30.01.2023 · 13 (2) · 260
DOI: 10.3390/biom13020260 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 30.01.2023. Verfasst von John Lenon de Souza Santos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 40296-710, Brazil. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Maria Emília, CNPq, CAPES.
Abstract (Originalsprache)
Autism spectrum disorders (ASD) are a group of complex neurodevelopmental disorders that affect communication and social interactions and present with restricted interests and repetitive behavior patterns. The susceptibility to ASD is strongly influenced by genetic/heritable factors; however, there is still a large gap in understanding the cellular and molecular mechanisms underlying the neurobiology of ASD. Significant progress has been made in identifying ASD risk genes and the possible convergent pathways regulated by these gene networks during development. The breakthrough of cellular reprogramming technology has allowed the generation of induced pluripotent stem cells (iPSCs) from individuals with syndromic and idiopathic ASD, providing patient-specific cell models for mechanistic studies. In the past decade, protocols for developing brain organoids from these cells have been established, leading to significant advances in the in vitro reproducibility of the early steps of human brain development. Here, we reviewed the most relevant literature regarding the application of brain organoids to the study of ASD, providing the current state of the art, and discussing the impact of such models on the field, limitations, and opportunities for future development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 40296-710, Brazil.
- Center for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador 41253-190, Brazil.
- D'Or Institute for Research and Education (IDOR), Salvador 41253-190, Brazil.
ORCID-Profile: John Lenon de Souza Santos, Clarissa Araújo Gurgel Rocha
Förderung
- Fundação Maria Emília
- CNPq
- CAPES
Zitieren
APA
Santos, J. L. S., Araújo, C. A., Rocha, C. A. G., Costa-Ferro, Z. S. M., & Souza, B. S. F. (2023). Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids. Biomolecules, 13(2), 260. https://doi.org/10.3390/biom13020260
Vancouver
Santos JLS, Araújo CA, Rocha CAG, Costa-Ferro ZSM, Souza BSF. Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids. Biomolecules. 2023;13(2):260. doi:10.3390/biom13020260
BibTeX
@article{Santos2023,
author = {Santos, John Lenon de Souza and Araújo, Cecília de Almeida and Rocha, Clarissa Araújo Gurgel and Costa-Ferro, Zaquer Suzana Munhoz and Souza, Bruno Solano de Freitas},
title = {Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {2},
pages = {260},
doi = {10.3390/biom13020260}
}
EUVIMED